Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -4.95% | 3.27% | 14.61% | 1.17% | 0.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.95% | 3.27% | 14.61% | 1.17% | 0.66% |
| Cost of Revenue | -0.48% | 12.53% | -0.07% | 10.53% | 7.48% |
| Gross Profit | -8.73% | -3.18% | 29.60% | -5.80% | -4.49% |
| SG&A Expenses | -31.29% | -10.71% | 6.51% | 17.29% | 31.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.80% | -3.48% | 6.81% | 16.19% | 22.96% |
| Operating Income | 41.99% | 13.39% | 1.35% | -45.45% | -67.40% |
| Income Before Tax | 36.64% | -53.96% | -3.83% | -157.63% | -251.29% |
| Income Tax Expenses | -- | -- | -- | 22.22% | -- |
| Earnings from Continuing Operations | 36.61% | -54.66% | -3.83% | -157.78% | -251.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.61% | -54.66% | -3.83% | -157.78% | -251.29% |
| EBIT | 41.99% | 13.39% | 1.35% | -45.45% | -67.40% |
| EBITDA | 40.51% | 7.71% | -0.17% | -71.60% | -113.38% |
| EPS Basic | 89.78% | 75.05% | 69.38% | -142.23% | 65.63% |
| Normalized Basic EPS | 89.79% | 85.41% | 69.80% | -155.08% | -108.22% |
| EPS Diluted | 89.78% | 75.05% | 69.38% | -142.23% | 65.63% |
| Normalized Diluted EPS | 89.79% | 85.41% | 69.80% | -155.08% | -108.22% |
| Average Basic Shares Outstanding | 520.45% | 519.87% | 239.09% | 36.83% | 922.23% |
| Average Diluted Shares Outstanding | 520.45% | 519.87% | 239.09% | 36.83% | 922.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
